PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1739329
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1739329
Cancer Insurance
Global Cancer Insurance Market to Reach US$142.0 Billion by 2030
The global market for Cancer Insurance estimated at US$80.9 Billion in the year 2024, is expected to reach US$142.0 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2024-2030. Individual Insurance Plan, one of the segments analyzed in the report, is expected to record a 11.3% CAGR and reach US$87.1 Billion by the end of the analysis period. Growth in the Supplement Insurance Plan segment is estimated at 7.5% CAGR over the analysis period.
The U.S. Market is Estimated at US$21.3 Billion While China is Forecast to Grow at 9.4% CAGR
The Cancer Insurance market in the U.S. is estimated at US$21.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$22.5 Billion by the year 2030 trailing a CAGR of 9.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.2% and 8.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.
Global Cancer Insurance Market - Key Trends & Drivers Summarized
Why Is Cancer Insurance Gaining Strategic Importance in Personal Financial Planning and Health Risk Protection?
Cancer insurance is becoming an essential layer of financial protection in response to the rising global burden of cancer and the high out-of-pocket costs associated with its diagnosis, treatment, and long-term management. Unlike standard health insurance, cancer-specific policies are designed to provide lump-sum payouts or reimbursements that can be used flexibly-for medical expenses, travel for treatment, loss of income, or supportive care. As cancer incidence increases across both developed and emerging markets, individuals and families are recognizing the value of specialized insurance to mitigate the financial volatility of a critical illness event.
The unpredictable nature of cancer diagnosis, treatment duration, and therapy costs-including chemotherapy, radiation, immunotherapy, and targeted drugs-underscores the relevance of standalone or supplemental cancer insurance policies. Employers, insurers, and financial advisors are increasingly recommending cancer insurance as part of comprehensive health and wellness planning, especially for high-risk individuals, aging populations, or those with limited access to universal healthcare.
How Are Product Innovation and Digital Distribution Expanding Access to Cancer Insurance Solutions?
Insurers are launching modular and tiered cancer insurance products that cater to varied demographic needs, offering coverage based on cancer stage, type, or recurrence status. Policies now include early diagnosis benefits, income replacement, and coverage for non-medical expenses such as home modifications and palliative care. Some plans also integrate second-opinion services, tele-oncology support, and wellness programs for cancer prevention and survivorship.
Digital platforms are driving product discovery, quote generation, and policy issuance with greater transparency and speed. Mobile apps, online calculators, and AI-based risk assessment tools are enhancing customer engagement and enabling targeted marketing for high-risk groups. Embedded insurance offerings-bundled with credit cards, digital wallets, or employer benefit programs-are further expanding reach, particularly in underpenetrated segments. These innovations are lowering barriers to entry and aligning cancer insurance with evolving consumer expectations around personalization and convenience.
Where Is Demand for Cancer Insurance Rising and Which Market Segments Are Driving Uptake?
North America and parts of Europe remain mature markets for cancer insurance, supported by high healthcare costs and gaps in standard insurance plans. In the U.S., where cancer treatment expenses can easily exceed six figures, supplemental cancer policies are commonly marketed to middle-income and retiree demographics. Europe sees moderate uptake through employer-sponsored plans and voluntary top-up coverage models.
Asia-Pacific is emerging as a high-growth region, driven by rapidly increasing cancer incidence, rising healthcare awareness, and underinsurance in markets such as India, China, Indonesia, and the Philippines. Insurers in these regions are targeting middle-class consumers, gig workers, and rural populations with affordable, simplified products distributed via bancassurance, mobile networks, and fintech platforms. Demand is especially strong among first-time policyholders seeking low-premium protection against high-impact health events.
What Is Fueling the Global Growth of the Cancer Insurance Market?
The global cancer insurance market is expanding on the back of rising cancer prevalence, increasing financial literacy, and the growing recognition of insurance as a tool for health risk management. Aging populations, urban lifestyle shifts, and environmental risk factors are driving cancer rates upward, while medical inflation continues to outpace income growth in many regions. As a result, insurers are positioning cancer-specific products as critical safeguards within broader health and financial security portfolios.
Strategic alliances between insurers, hospitals, and digital health platforms are enhancing claims processing, early detection initiatives, and treatment navigation-strengthening the value proposition of cancer insurance. Regulatory support for microinsurance, product standardization, and digital onboarding is also enabling penetration in price-sensitive markets. As cancer becomes a long-term health challenge with significant economic implications, a defining question shapes the market’s trajectory: Can cancer insurance evolve into an inclusive, responsive, and data-driven solution that delivers meaningful financial protection-while supporting prevention, early detection, and survivorship in a rapidly changing healthcare landscape?
SCOPE OF STUDY:
The report analyzes the Cancer Insurance market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Insurance Plan (Individual Plan, Supplement Plan, Critical Illness Plan); Gender (Male, Female)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 32 Featured) -
- Aegon N.V.
- Aflac Incorporated
- Allianz SE
- American Fidelity Assurance Company
- Anthem, Inc.
- Aviva plc
- AXA S.A.
- Bajaj Allianz General Insurance
- Bharti AXA General Insurance
- Blue Cross Blue Shield Association
- Cigna Corporation
- Colonial Life & Accident Insurance
- Desjardins Group
- ICICI Prudential Life Insurance
- Kaiser Permanente
- Liberty Mutual Insurance
- ManipalCigna Health Insurance
- Max Life Insurance Company Limited
- MetLife, Inc.
- Mutual of Omaha Insurance Company
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.
We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.
As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.
To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!
APRIL 2025: NEGOTIATION PHASE
Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.
JULY 2025 FINAL TARIFF RESET
Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.
Reciprocal and Bilateral Trade & Tariff Impact Analyses:
USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.
Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.
COMPLIMENTARY PREVIEW
Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Cancer Insurance - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Rising Cancer Incidence and Treatment Costs Spur Demand for Specialized Cancer Insurance Products
- Lump Sum Payout Models Offer Financial Flexibility for Out-of-Pocket Cancer Treatment Expenses
- Policy Riders for Critical Illness and Hospital Cash Expand Customization Options in Cancer Plans
- Insurers Launch Digital Cancer Coverage With Early Diagnosis Incentives and Wellness Features
- Integration With Tele-Oncology Services and Navigation Support Adds Value for Policyholders
- Employer-Provided Cancer Insurance Plans Grow in Popularity as Part of Enhanced Health Benefits
- Consumer Awareness Campaigns Improve Understanding of Coverage Scope and Claim Triggers
- Cancer Insurance Policies Gain Traction in Regions With Limited Universal Healthcare Coverage
- Cross-Selling With Life and Health Insurance Portfolios Supports Customer Retention Strategies
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Cancer Insurance Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Cancer Insurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World 6-Year Perspective for Cancer Insurance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Individual Plan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 5: World 6-Year Perspective for Individual Plan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 6: World Recent Past, Current & Future Analysis for Supplement Plan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 7: World 6-Year Perspective for Supplement Plan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Critical Illness Plan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World 6-Year Perspective for Critical Illness Plan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Male by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 11: World 6-Year Perspective for Male by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
- TABLE 12: World Recent Past, Current & Future Analysis for Female by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 13: World 6-Year Perspective for Female by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
III. MARKET ANALYSIS
- UNITED STATES
- Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 14: USA Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 15: USA 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
- TABLE 16: USA Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 17: USA 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
- CANADA
- TABLE 18: Canada Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 19: Canada 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
- TABLE 20: Canada Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 21: Canada 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
- JAPAN
- Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 22: Japan Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 23: Japan 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
- TABLE 24: Japan Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 25: Japan 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
- CHINA
- Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 26: China Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 27: China 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
- TABLE 28: China Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 29: China 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
- EUROPE
- Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 30: Europe Recent Past, Current & Future Analysis for Cancer Insurance by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 31: Europe 6-Year Perspective for Cancer Insurance by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
- TABLE 32: Europe Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 33: Europe 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
- TABLE 34: Europe Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 35: Europe 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
- FRANCE
- Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 36: France Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 37: France 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
- TABLE 38: France Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 39: France 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
- GERMANY
- Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 40: Germany Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 41: Germany 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
- TABLE 42: Germany Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 43: Germany 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
- ITALY
- TABLE 44: Italy Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 45: Italy 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
- TABLE 46: Italy Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 47: Italy 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
- UNITED KINGDOM
- Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 48: UK Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 49: UK 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
- TABLE 50: UK Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: UK 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
- REST OF EUROPE
- TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 53: Rest of Europe 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
- TABLE 54: Rest of Europe Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 55: Rest of Europe 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
- ASIA-PACIFIC
- Cancer Insurance Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: Asia-Pacific 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
- TABLE 58: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 59: Asia-Pacific 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
- REST OF WORLD
- TABLE 60: Rest of World Recent Past, Current & Future Analysis for Cancer Insurance by Insurance Plan - Individual Plan, Supplement Plan and Critical Illness Plan - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 61: Rest of World 6-Year Perspective for Cancer Insurance by Insurance Plan - Percentage Breakdown of Value Sales for Individual Plan, Supplement Plan and Critical Illness Plan for the Years 2025 & 2030
- TABLE 62: Rest of World Recent Past, Current & Future Analysis for Cancer Insurance by Gender - Male and Female - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: Rest of World 6-Year Perspective for Cancer Insurance by Gender - Percentage Breakdown of Value Sales for Male and Female for the Years 2025 & 2030
IV. COMPETITION
